Amplify Energy Director Coghill Buys 939,600 Shares in Three-Day Period

Amplify Energy Corp.[AMPY] reports that Director Clint D. Coghill has made a series of purchases of the company's shares. Specifically, Mr. Coghill acquired 117,420 shares on August 12, 2025, at a price of $3.69 per share, 167,086 shares on August 13, 2025, at a price of $3.88 per share, and 65,494 shares on August 14, 2025, at a price of $3.89 per share. These transactions demonstrate Mr. Coghill's confidence in the company's future prospects and his commitment to supporting its growth through strategic investments.

Amplify Energy Corp. [AMPY] has reported that Director Clint D. Coghill has made a series of significant share purchases. According to the company's SEC Form 4 filing [1], Mr. Coghill acquired 117,420 shares on August 12, 2025, at a price of $3.69 per share, 167,086 shares on August 13, 2025, at a price of $3.88 per share, and 65,494 shares on August 14, 2025, at a price of $3.89 per share.

These transactions demonstrate Mr. Coghill's confidence in the company's future prospects and his commitment to supporting its growth through strategic investments. The purchases come amid a period of positive news for the company, with shares rising 4.69% intraday on August 12, 2025, following the publication of positive clinical trial results by Elicio Therapeutics, Inc. [2].

Additionally, the company's President and Chief Financial Officer, James Frew, also made a significant purchase of 75,000 shares on August 11 and 12, 2025, for a total of $267,500 [3]. This further underscores the company's strong management team's belief in its growth potential.

References:
[1] https://www.stocktitan.net/sec-filings/AMPY/form-4-amplify-energy-corp-insider-trading-activity-eb81fe806052.html
[2] https://www.ainvest.com/news/amplify-energy-corp-shares-rise-4-69-intraday-elicio-therapeutics-published-positive-clinical-trial-results-eli-002-2508/
[3] https://www.tradingview.com/news/tradingview:fc9b331abb69f:0-amplify-energy-corp-officer-james-frew-acquires-75-000-shares/